ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 37 filers reported holding ATYR PHARMA INC in Q4 2022. The put-call ratio across all filers is 12.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,757 | -96.9% | 8,565 | -95.7% | 0.00% | -100.0% |
| Q3 2022 | $604,000 | -43.0% | 201,361 | -46.2% | 0.00% | -33.3% |
| Q2 2022 | $1,060,000 | -68.3% | 374,395 | -40.1% | 0.01% | -68.4% |
| Q1 2022 | $3,344,000 | -28.4% | 625,000 | 0.0% | 0.02% | -17.4% |
| Q4 2021 | $4,669,000 | -17.7% | 625,000 | 0.0% | 0.02% | -8.0% |
| Q3 2021 | $5,675,000 | – | 625,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 624,000 | $1,367 | 2.16% |
| Tikvah Management LLC | 1,350,833 | $2,958,324 | 1.41% |
| VR Adviser, LLC | 1,171,436 | $2,565,445 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 123,430 | $270,312 | 0.04% |
| FEDERATED HERMES, INC. | 5,231,600 | $11,457,204 | 0.03% |
| Alyeska Investment Group, L.P. | 1,378,747 | $3,019,456 | 0.03% |
| Walleye Capital LLC | 750,000 | $1,642,500 | 0.03% |
| Tower Research Capital LLC (TRC) | 17,443 | $38 | 0.00% |
| CITIGROUP INC | 428,460 | $938,327 | 0.00% |
| PFS Partners, LLC | 406 | $890 | 0.00% |